Kaja Bator
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kaja Bator has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Iwona Matus
Faculty of Medicine, Wroclaw Medical University, Poland / Wydział Lekarski, Uniwersytet Medyczny we Wrocławiu, Polska
4 shared publications - Weronika Machaj
Department of General and Interventional Radiology and Neuroradiology, Wroclaw Medical University, Wroclaw, Poland
4 shared publications - Krystian Szypuła
Łańcut Medical Center, Łańcut, Poland / Centrum Medyczne w Łańcucie, Polska
3 shared publications - Adrian Korbecki
Department of General and Interventional Radiology and Neuroradiology, Medical University Hospital, Wroclaw, Poland; Hetalox sp. z o.o., Wroclaw, Poland
1 shared publication - Aleksandra Krzemienowska-Cebulla
Faculty of Medicine, Wroclaw Medical University, Wybrzeże L. Pasteura 1, 50-367 Wroclaw, Poland
1 shared publication - Andrzej Szuba
Department of Angiology and Internal Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland
1 shared publication
Latest Publications
- 31 March 2024
- Published by Index Copernicus in Polish Journal of Sports Medicine
- Vol. 40 (1) , 215-221
The impact of COVID-19 on cardiovasuar system
- 31 March 2024
- Published by Index Copernicus in Polish Journal of Sports Medicine
- Vol. 40 (1) , 215-221
The impact of COVID-19 on cardiovasuar system
- 31 March 2024
- Published by Index Copernicus in Polish Journal of Sports Medicine
- Vol. 40 (1) , 221-227
The impact of COVID-19 on cardiovasuar system
- 31 March 2024
- Published by Index Copernicus in Polish Journal of Sports Medicine
- Vol. 40 (1) , 221-227
The impact of COVID-19 on cardiovasuar system
- Open Access
- 16 February 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 61, 26-38
Hematologic complications in vascular malformations: A case study of 2 patients
Vascular malformations are congenital vascular anomalies resulting from a disruption in the vasculogenesis process. (1) They are congenital changes that enlarge as the child develops and do not undergo spontaneous involution. They can be classified based on the type of vessels involved (capillary, arterial, venous, lymphatic, mixed) and the nature of the vascular flow (low-flow and high-flow). The clinical presentation of vascular malformations is highly diverse, and despite being congenital, they can remain asymptomatic for a long time, complicating the diagnostic process. (1,3) The presence of malformations carries the risk of health-threatening complications. One such complication is Kasabach-Merritt syndrome, characterized by thrombocytopenia, microangiopathic hemolytic anemia, and consumptive coagulopathy in the presence of a rapidly enlarging vascular tumor. (4,5) Another threat is a coagulopathy limited to the vascular anomaly (LIC). It is characterized by elevated D-dimers and fibrin degradation products, low levels of fibrinogen, FV, FVIII, FXIII, and antithrombin, and sometimes mild to moderate thrombocytopenia. (6,7) Early implementation of anticoagulant therapy allows for the avoidance of health-threatening conditions and the development of disseminated intravascular coagulation syndrome (DIC). (8)
- 16 February 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 61, 26-38
Open AccessHematologic complications in vascular malformations: A case study of 2 patients
Vascular malformations are congenital vascular anomalies resulting from a disruption in the vasculogenesis process. (1) They are congenital changes that enlarge as the child develops and do not undergo spontaneous involution. They can be classified based on the type of vessels involved (capillary, arterial, venous, lymphatic, mixed) and the nature of the vascular flow (low-flow and high-flow). The clinical presentation of vascular malformations is highly diverse, and despite being congenital, they can remain asymptomatic for a long time, complicating the diagnostic process. (1,3) The presence of malformations carries the risk of health-threatening complications. One such complication is Kasabach-Merritt syndrome, characterized by thrombocytopenia, microangiopathic hemolytic anemia, and consumptive coagulopathy in the presence of a rapidly enlarging vascular tumor. (4,5) Another threat is a coagulopathy limited to the vascular anomaly (LIC). It is characterized by elevated D-dimers and fibrin degradation products, low levels of fibrinogen, FV, FVIII, FXIII, and antithrombin, and sometimes mild to moderate thrombocytopenia. (6,7) Early implementation of anticoagulant therapy allows for the avoidance of health-threatening conditions and the development of disseminated intravascular coagulation syndrome (DIC). (8)
- Open Access
- 29 December 2023
- Published by Medical Communications Sp. z.o.o. in Pediatria i Medycyna Rodzinna
- Vol. 19 (4) , 470-474
Ocular abnormalities in Mowat–Wilson syndrome – a case series of four patients
- 29 December 2023
- Published by Medical Communications Sp. z.o.o. in Pediatria i Medycyna Rodzinna
- Vol. 19 (4) , 470-474
Open AccessOcular abnormalities in Mowat–Wilson syndrome – a case series of four patients